These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29228971)

  • 1. Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes.
    Gustafsson G; Lindström V; Rostami J; Nordström E; Lannfelt L; Bergström J; Ingelsson M; Erlandsson A
    J Neuroinflammation; 2017 Dec; 14(1):241. PubMed ID: 29228971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage.
    Lindström V; Gustafsson G; Sanders LH; Howlett EH; Sigvardson J; Kasrayan A; Ingelsson M; Bergström J; Erlandsson A
    Mol Cell Neurosci; 2017 Jul; 82():143-156. PubMed ID: 28450268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes.
    Rostami J; Holmqvist S; Lindström V; Sigvardson J; Westermark GT; Ingelsson M; Bergström J; Roybon L; Erlandsson A
    J Neurosci; 2017 Dec; 37(49):11835-11853. PubMed ID: 29089438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.
    Prots I; Grosch J; Brazdis RM; Simmnacher K; Veber V; Havlicek S; Hannappel C; Krach F; Krumbiegel M; Schütz O; Reis A; Wrasidlo W; Galasko DR; Groemer TW; Masliah E; Schlötzer-Schrehardt U; Xiang W; Winkler J; Winner B
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7813-7818. PubMed ID: 29991596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons.
    Chavarría C; Rodríguez-Bottero S; Quijano C; Cassina P; Souza JM
    Biochem J; 2018 Oct; 475(19):3153-3169. PubMed ID: 30185433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress of immunotherapy of anti-α-synuclein in Parkinson's disease.
    Wang Z; Gao G; Duan C; Yang H
    Biomed Pharmacother; 2019 Jul; 115():108843. PubMed ID: 31055236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading.
    Loria F; Vargas JY; Bousset L; Syan S; Salles A; Melki R; Zurzolo C
    Acta Neuropathol; 2017 Nov; 134(5):789-808. PubMed ID: 28725967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease.
    Hu Q; Uversky VN; Huang M; Kang H; Xu F; Liu X; Lian L; Liang Q; Jiang H; Liu A; Zhang C; Pan-Montojo F; Zhu S
    Biochim Biophys Acta; 2016 Oct; 1862(10):1883-90. PubMed ID: 27425033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
    Doucet M; El-Turabi A; Zabel F; Hunn BHM; Bengoa-Vergniory N; Cioroch M; Ramm M; Smith AM; Gomes AC; Cabral de Miranda G; Wade-Martins R; Bachmann MF
    PLoS One; 2017; 12(8):e0181844. PubMed ID: 28797124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of α-synuclein in oligodendroglial cells.
    Pukaß K; Goldbaum O; Richter-Landsberg C
    J Neurochem; 2015 Oct; 135(1):194-205. PubMed ID: 26212128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent alpha-synuclein accumulation is correlated with elevation of mitochondrial TRPC3 in the brains of monkeys and mice.
    Chen M; Liu J; Lu Y; Duan C; Lu L; Gao G; Chan P; Yu S; Yang H
    J Neural Transm (Vienna); 2017 Apr; 124(4):441-453. PubMed ID: 27904950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.
    Weihofen A; Liu Y; Arndt JW; Huy C; Quan C; Smith BA; Baeriswyl JL; Cavegn N; Senn L; Su L; Marsh G; Auluck PK; Montrasio F; Nitsch RM; Hirst WD; Cedarbaum JM; Pepinsky RB; Grimm J; Weinreb PH
    Neurobiol Dis; 2019 Apr; 124():276-288. PubMed ID: 30381260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of α-Synuclein Oligomers in Parkinson's Disease.
    Du XY; Xie XX; Liu RT
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Protein Complementation Demonstrates Presynaptic α-Synuclein Oligomerization and Age-Dependent Accumulation of 8-16-mer Oligomer Species.
    Kiechle M; von Einem B; Höfs L; Voehringer P; Grozdanov V; Markx D; Parlato R; Wiesner D; Mayer B; Sakk O; Baumann B; Lukassen S; Liss B; Ekici AB; Ludolph AC; Walther P; Ferger B; McLean PJ; Falkenburger BH; Weishaupt JH; Danzer KM
    Cell Rep; 2019 Nov; 29(9):2862-2874.e9. PubMed ID: 31775051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Golgi-localized, gamma ear-containing, ARF-binding (GGA) protein family alters alpha synuclein (α-syn) oligomerization and secretion.
    von Einem B; Eschbach J; Kiechle M; Wahler A; Thal DR; McLean PJ; Weishaupt JH; Ludolph AC; von Arnim CAF; Danzer KM
    Aging (Albany NY); 2017 Jul; 9(7):1677-1697. PubMed ID: 28722658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.
    Takahashi M; Ko LW; Kulathingal J; Jiang P; Sevlever D; Yen SH
    Eur J Neurosci; 2007 Aug; 26(4):863-74. PubMed ID: 17714183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the Astrocytic Clearance of Extracellular α-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury.
    Hua J; Yin N; Xu S; Chen Q; Tao T; Zhang J; Ding J; Fan Y; Hu G
    Cell Mol Neurobiol; 2019 Oct; 39(7):1017-1028. PubMed ID: 31165943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation.
    Fagerqvist T; Lindström V; Nordström E; Lord A; Tucker SM; Su X; Sahlin C; Kasrayan A; Andersson J; Welander H; Näsström T; Holmquist M; Schell H; Kahle PJ; Kalimo H; Möller C; Gellerfors P; Lannfelt L; Bergström J; Ingelsson M
    J Neurochem; 2013 Jul; 126(1):131-44. PubMed ID: 23363402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.